Hereditary causes of disturbed iron homeostasis in the central nervous system

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 267-281

  Ponka, Prem ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Aceruloplasminemia; Ceruloplasmin; Ferritin; Frataxin; Friedreich's ataxia; Iron; Iron regulatory protein 2 (IRP2); IRP2 deficiency; Neuroferritinopathy; Pantothenate kinase 2 deficiency

Indexed keywords

CERULOPLASMIN; CYSTEINE; FERRITIN; FRATAXIN; IRON; IRON REGULATORY PROTEIN 2; IRON SULFUR PROTEIN; OXYGEN RADICAL;

ACERULOPLASMINEMIA; ALLELE; ATAXIA; AUTOSOMAL RECESSIVE DISORDER; BIOENERGY; BRADYKINESIA; BRAIN; CATALYSIS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLAR ATAXIA; CERULOPLASMIN GENE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; EXTRAPYRAMIDAL SYMPTOM; FRATAXIN GENE; FRIEDREICH ATAXIA; GENE; GENE DISRUPTION; GENE MUTATION; GLOBUS PALLIDUS; HALLERVORDEN SPATZ DISEASE; HOMEOSTASIS; HUMAN; INTESTINE MUCOSA; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; LIVER; MITOCHONDRIAL TOXICITY; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROFERRITINOPATHY; ONSET AGE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PANCREAS; PANK2 GENE; PROTEIN AGGREGATION; RETINA DISEASE; REVIEW; TRANSLATION REGULATION; TREMOR; WHITE MATTER;

ATAXIA;

EID: 1842608738     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.022     Document Type: Review

References (96)

1. MCCORD, J.M. 1998. Iron, free radicals, and oxidative injury. Semin. Hematol. 35: 5-12.
2. HALLIWELL, B. 2001. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18: 685-716.
3. RICHARDSON, D.R. & P. PONKA. 1997. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331: 1-40.
4. PONKA, P., C. BEAUMONT & D.R. RICHARDSON. 1998. Function and regulation of transferrin and ferritin. Semin. Hematol. 35: 35-54.
5. KLAUSNER, R.D. & T. ROUAULT. 1998. The molecular basis of iron metabolism. In The Harvey Lectures. Series 92, p. 99.
6. AISEN, P., C. ENNS & M. WESSLING-RESNICK. 2001. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 33: 940-959.
7. PONKA, P. & C.N. LOK. 1999. The transferrin receptor: role in health and disease. Int. J. Biochem. Cell Biol. 31: 1111-1137.
8. LEVY, J.E., O. JIN, Y. FUKIWARA et al. 1999. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21: 396-399.
9. KAWABATA, H., R. YANG, T. HIRAMA et al. 1999. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J. Biol. Chem. 274: 20826-20832.
10. ROETTO, A., F. DARAIO, F. ALBERTI et al. 2002. Hemochromatosis due to mutations in transferrin receptor. Blood Cells Mol. Dis. 29: 465-470.
11. FLEMING, R.E., J.R. AHMANN, M.C. MIGAS et al. 2002. Targeted mutagenesis of the murine transferrin receptor-2 gene products hemochromatosis. Proc. Natl. Acad. Sci. USA 99: 10653-10658.
12. FEDER, J.N., A. GNIRKE, W. THOMAS et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 4: 399-407.
13. AJIOKA, R.S. & J.P. KUSHNER. 2002. Hereditary hemochromatosis. Semin. Hematol. 39: 235-241.
14. AROSIO, P. & Z. LEVI. 2002. Ferritin, iron homeostasis, and oxidative damage. Free Radical Biol. Med. 33: 457-463.
15. FERREIRA, C., D. BUCCHINI, M.E. MARTIN et al. 2000. Early embryonic lethality of H ferritin gene deletion in mice. J. Biol. Chem. 275: 3021-3024.
16. CAIRO, G. & A. PIETRANGELO. 2000. Iron regulatory proteins in pathobiology. Biochem. J. 352: 241-250.
17. MIKULITS, W., M. SCHRANZHOFER, H. BEUG et al. 1999. Post-transcriptional control via iron-responsive elements: the impact of aberrations in hereditary disease. Mutat. Res. 437: 219-230.
18. LAVAUTE, T., S. SMITH, S. COOPERMAN et al. 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27: 209-214.
19. FLEMING, M.D., C.C. TRENOR III, M.A. SU et al. 1997. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16: 383-386.
20. GUNSHIN, H., B. MACKENZIE, U.V. BERGER et al. 1997. Cloning and characterization of a mammalian proton-coupled metal ion transporter. Nature 388: 482-488.
21. MCKIE, A.T., D. BARROW, G.O. LATUNDE-DAOA et al. 2001. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759.
22. DONOVAN, A., A. BROWNLIE, Y. ZHOU et al. 2000. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781.
23. MCKIE, A.T., P. MARCIANA, A. ROLFS et al. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 4: 299-309.
24. ABBOUO, S. & D.J. HAILE. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275: 19906-19912.
25. MONTOSI, G., A. DONOVAN, A. TOTARO et al. 2001. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108: 619-623.
26. HELLMAN, N.E. & J.D. GITLIN. 2002. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22: 439-458.
27. NITTIS, T. & J.D. GITLIN. 2002. The copper-iron connection: hereditary aceruloplasminemia. Semin. Hematol. 39: 282-289.
28. VULPE, C.D., Y.M. KUO, T.L. MURPHY et al. 1999. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the Sla mouse. Nat. Genet. 21: 195-199.
29. ANOERSON, G.J., D.M. FRAZER, A.T. MCKIE et al. 2002. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol. Dis. 29: 367-375.
30. PANDOLFO, M. 1999. Friedreich's ataxia: clinical aspects and pathogenesis. Semin. Neurol. 19: 311-321.
31. PUCCIO, H. & M. KOENIG. 2002. Friedreich ataxia: a paradigm for mitochondrial diseases. Curr. Opin. Genet. Dev. 12: 272-277.
32. COX, T.M. 1997. Erythropoietic protoporphyria. J. Inherit. Metab. Dis. 20: 258-269.
33. DRYSOALE, J., P. AROSIO, R. INVERNIZZI et al. 2002. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol. Dis. 29: 376-383.
34. CAZZOLA, M., R. INVERNIZZI, G. BERGAMASCHI et al. 2003. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101: 1996-2000.
35. MAINES, M.D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554.
36. POSS, K.D. & S. TONEGAWA. 1997. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94: 10919-10924.
37. POSS, K.D. & S. TONEGAWA. 1997. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94: 10925-10930.
38. YACHIE, A., Y. NIIDA, T. WADA et al. 1999. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103: 129-135.
39. DORE, S., K. GOTO, S. SAMPEI et al. 2000. Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia. Neuroscience 99: 587-592.
40. BURNETT, A.L., D.G. DEVIN, J.L. KRIEGSFELD et al. 1998. Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. Nat. Med. 4: 84-87.
41. PARK, C.H., E.V. VALORE, A.J. WARING & T. GANZ. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276: 7806-7810.
42. NICOLAS, G., M. BENNOUN, I. DEVAUX et al. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98: 8780-8785.
43. NICOLAS, G., M. BENNOUN, A. PORTEAU et al. 2002. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99: 4596-4601.
44. NICOLAS, G., L. VIATTE, M. BENNOUN et al. 2002. Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29: 327-335.
45. LEIBOLD, E.A., L.C. GAHRING & S.W. ROGERS. 2001. Immunolocalization of iron regulatory protein expression in the murine central nervous system. Histochem. Cell. Biol. 114: 195-203.
46. BURDO, J.R., S.L. MENZIES, I.A. SIMPSON et al. 2001. Distribution of divalent metal transporter I and metal transport protein I in the normal and Belgrade rat. J. Neurosci. Res. 66: 1198-1207.
47. SIDDAPPA, A.J., R.B. RAO, J.D. WOBKEN et al. 2002. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J. Neurosci. Res. 68: 761-765.
48. CONNOR, J.R. 2003. Iron transport proteins in the diseased brain. J. Neurosci. 207: 112-113.
49. MIRET, S., R.J. SIMPSON & A.T. MCKIE. 2003. Physiology and molecular biology of dietary iron absorption. Annu. Rev. Nutr. 23: 283-301.
50. GRASBECK, R., R. MAJURI, I. KOUVONEN & R. TENHUNEN. 1982. Spectral and other studies on the intestinal haem receptor of the pig. Biochim. Biophys. Acta 700: 137-142.
51. WORTHINGTON, M.T., S.M. COHN, S.K. MILLER et al. 2001. Characterization of a human plasma membrane heme transporter in intestinal and hepatocyte cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1172-G1177.
52. HENTZE, M.W. & L.C. KUHN. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93: 8175-8182.
53. PANTOPOULOS, K. & M.W. HENTZE. 1995. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 14: 2917-2924.
54. 2) control mammalian iron metabolism by different pathways. Mol. Cell. Biol. 16: 3781-3788.
55. KIM, S. & P. PONKA. 1999. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2. J. Biol. Chem. 274: 33035-33042.
56. KIM, S. & P. PONKA. 2000. Effects of interferon-γ and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275: 6220-6226.
57. MORGAN, E.H. & T. MOOS. 2002. Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev. Neurosci. 24: 106-113.
58. CURTIS, A.R., C. FEY, C.M. MORRIS et al. 2001. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 28: 350-354.
59. ROUAULT, T.A. 2001. Iron on the brain. Nat. Genet. 28: 299-300.
60. KIM, S. & P. PONKA. 2002. Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc. Natl. Acad. Sci. USA 99: 12214-12219.
61. BECKER, E. & D.R. RICHARDSON. 2001. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. Int. J. Biochem. Cell Biol. 33: 1-10.
62. LAMARCHE, J.B., M. COTE & B. LEMIEUX. 1980. The cardiomyopathy of Friedreich's ataxia: morphological observations in 3 cases. Can. J. Neurol. Sci. 7: 389-396.
63. SANCHEZ-CASIS, G., M. COTE & A. BARBEAU. 1976. Pathology of the heart in Friedreich's ataxia: review of the literature and report of one case. Can. J. Neurol. Sci. 3: 349-354.
64. PUCCIO, H., D. SIMON, M. COSSEE et al. 2001. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect, and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27: 181-186.
65. PONKA, P. 1997. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89: 1-25.
66. BECKER, E.M., J.M. GREER, P. PONKA & D.R. RICHARDSON. 2002. Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization. Blood 99: 3813-3822.
67. AARDON, O., J. KAPLAN & B.D. MARTIN. 2002. Iron uptake in yeast. In Molecular and Cellular Iron Transport, pp. 375-393. Dekker. New York.
68. BABCOCK, M., D. DE SILVA, R. OAKS et al. 1997. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276: 1709-1712.
69. RADISKY, D.C., M.C. BABCOCK & J. KAPLAN. 1999. The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle. J. Biol. Chem. 274: 4497-4499.
70. MUHLENHOFF, U., J. GERBER, N. RICHHARDT & R. LILL. 2003. Components involved in assembly and dislocation of iron-sulfur clusters on the scaffold protein Isu1p. EMBO J. 22: 4815-4825.
71. GERBER, J., U. MUHLENHOFF & R. LILL. 2003. An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep. 4: 906-911.
72. SWAIMAN, K.F. 2001. Hallervorden-Spatz syndrome. Pediatr. Neurol. 25: 102-108.
73. HAYFLICK, S.J. 2003. Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name. Curr. Opin. Pediatrics 15: 572-577.
74. ZHOU, B., S.K. WESTAWAY, B. LEVINSON et al. 2001. A novel panthothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28: 345-349.
75. PERRY, T.L., M.G. NORMAN, V.W. YONG et al. 1985. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann. Neurol. 18: 482-489.
76. YOON, S.J., Y.Y. KOH, R.A. FLOYD & J.W. PARK. 2000. Copper, zinc superoxide dismutase enhances DNA damage and mutagenicity induced by cysteine/iron. Mutat. Res. 448: 97-104.
77. FOX, P.L. The copper-iron chronicles: the story of an intimate relationship. Biometals 16: 9-40.
78. OSAKI, S., D.A. JOHNSON & E. FRIEDEN. 1971. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. Biol. Chem. 246: 3018-3023.
79. OSAKI, S. & D.A. JOHNSON. 1969. Mobilization of liver iron by ferroxidase (ceruloplasmin). J. Biol. Chem. 244: 5757-5765.
80. HARRIS, Z.L., A.P. DURLEY, T.K. MAN & J.D. GITLIN. 1999. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 96: 10812-10817.
81. ASKWITH, C., D. EIDE, A. VANHO et al. 1994. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 76: 403-410.
82. STEARMAN, R., D.S. YUAN, Y. YAMAGUCHI-IWA et al. 1996. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271: 1552-1557.
83. KLOMP, L.W.J., Z.S. FARHANGRAZI, L.L. DUGAN et al. 1996. Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest. 98: 207-215.
84. KLOMP, L. W. & J.D. GITLIN. 1996. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5: 1989-1996.
85. PATEL, B.N. & S. DAVID. 1997. A novel glycosylphosphatidylinositol- anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272: 20185-20190.
86. PATEL, B.N., R.J. DUNN & S. DAVID. 2000. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275: 4305-4310.
87. JEONG, S.Y. & S. DAVID. 2003. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278: 27144-27148.
88. PATEL, B.N., R.J. DUNN, S.Y. JEONG et al. 2002. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22: 6578-6586.
89. MIYAJIMA, H., Y. NISHIMURA, K. MIZOGUCHI et al. 1987. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37: 761-767.
90. HARRIS, Z.L., Y. TAKAHASHI, H. MIYAJIMA et al. 1995. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92: 2539-2543.
91. YOSHIDA, K., K. FURIHATA, S. TAKEDA et al. 1995. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9: 267-272.
92. DAIMON, M., T. KATO, T. KAWANAMI et al. 1995. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem. Biophys. Res. Commun. 217: 89-95.
93. HARRIS, Z.L., M.D. MIGAS, A.E. HUGHES et al. 1996. Familial dementia due to a frameshift mutation in the ceruloplasmin gene. Q. J. Med. 89: 355-359.
94. OKAMOTO, N., S. WADA, T. OGA et al. 1996. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet. 97: 755-758.
95. HELLMAN, N.E., S. KONO, H. MIYAJIMA & J.D. GITLIN. 2002. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277: 1375-1380.
96. PONKA, P. 2003. Recent advances in cellular iron metabolism. J. Trace Elem. Exp. Med. 16: 201-217.